Goodwill Pharma Plc.
Goodwill Pharma is a dynamically developing pharmaceutical company founded in 1997, listed on Hungarian Stock Exchange. The company is known for its slogan "Good health - Good life - Good will," reflecting its commitment to the value of good health and faith in the future.
As one of the top ten pharmaceutical companies in Hungary, Goodwill Pharma is the creator of the Albert Szent-Györgyi product line and operates with more than 100 sales representatives and a storage capacity of over 6000 pallets. The company is fully integrated, from production through wholesale and distribution to consumer sales and marketing services.
Goodwill Pharma plays a crucial role in sales and marketing of pharmaceuticals in the CEE region, particularly in Hungary and Serbia. The company has a strong presence in 12 countries, with regional centers in Hungary, Serbia, and affiliates/companies in Poland, Slovakia, Romania, Croatia, Kosovo, Montenegro, Bosnia&Herczegovina, North-Macedonia, and distributor partners in Czech Republic, Albania.
The company specializes in rheumatology, infectious diseases, neurology, and various other medical fields. It offers a range of flagship products, including Albert Szent-Györgyi (ASG), Fortacell, Cartinorm, Makula komplex, Dermawill, and has a diverse pharmaceuticals portfolio, occupying a strong position in the market of dietary food supplements and medical devices.
With a strong commitment to EU Good Manufacturing Practices (GMP), FDA, and HACCP standards, Goodwill Pharma focuses on producing high-quality medicines and food supplements. For more information, visit https://goodwillpharma.com/
There is no investment information
No recent news or press coverage available for Goodwill Pharma Plc..